Longeveron Inc (LGVN)
1.6300 +0.0300 (+1.87%) 11:53 ET [NASDAQ]
1.6100 x 1 1.6300 x 2
Realtime by (Cboe BZX)
1.6100 x 1 1.6300 x 2
Realtime - - (-) -
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LGVN | XFOR | TENX | ||
| Company | Longeveron Inc | X4 Pharmaceuticals Inc | Tenax Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.6400 | 4.36 | 5.52 | ||
| High | 1.6400 | 4.81 | 5.55 | ||
| Low | 1.5600 | 4.03 | 5.48 | ||
| Last | 1.6300 | 4.06 | 5.50 | ||
| Change | +0.0300 | -0.29 | -0.16 | ||
| % Change | +1.87% | -6.67% | -2.83% | ||
| Volume | 23,449 | 201,091 | 1,819 | ||
| 20-Day Average Volume | 107,607 | 89,860 | 16,136 | ||
| Previous Close | 1.6000 | 4.35 | 5.67 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4967 | 5.94 | 5.60 | ||
| 20-Day Raw Stochastic | 65.08% | 1.69% | 45.95% | ||
| 20-Day Relative Strength | 52.06% | 28.04% | 44.13% | ||
| Weighted Alpha | -69.94 | -91.33 | +27.74 | ||
| Today's Opinion | 56% Sell | 100% Sell | 24% Sell | ||
| Previous Opinion | 56% Sell | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/23/25 | -32.45% since 04/23/25 | +0.37% since 04/23/25 | ||
| Low | 1.5600 on 04/30/25 | 4.03 on 04/30/25 | 5.31 on 04/24/25 | ||
| High | 1.8300 on 04/28/25 | 6.63 on 04/28/25 | 6.00 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +1.90% since 03/28/25 | -45.61% since 03/28/25 | -15.56% since 03/28/25 | ||
| Low | 1.2000 on 04/09/25 | 4.03 on 04/30/25 | 4.63 on 04/22/25 | ||
| High | 1.8300 on 04/28/25 | 7.50 on 03/31/25 | 6.59 on 03/31/25 | ||
| 3-Month | |||||
| %Chg | +0.62% since 01/30/25 | -79.46% since 01/30/25 | -8.67% since 01/30/25 | ||
| Low | 1.2000 on 04/09/25 | 4.03 on 04/30/25 | 4.63 on 04/22/25 | ||
| High | 1.9198 on 03/24/25 | 24.30 on 01/31/25 | 7.89 on 02/10/25 | ||
| 6-Month | |||||
| %Chg | -25.46% since 10/30/24 | -73.80% since 10/30/24 | +27.44% since 10/30/24 | ||
| Low | 1.2000 on 04/09/25 | 4.03 on 04/30/25 | 4.32 on 10/31/24 | ||
| High | 2.3100 on 11/12/24 | 26.83 on 12/31/24 | 7.89 on 02/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 23,885 | 25,156 | 23,501 | ||
| Shares Outstanding, K | 14,928 | 5,783 | 4,148 | ||
| Annual Sales | 2,390,000 | 2,560,000 | 0 | ||
| Annual Net Income | -15,970,000 | -37,450,000 | -17,600,000 | ||
| Last Quarter Sales | 600,000 | 1,430,000 | 0 | ||
| Last Quarter Net Income | -4,080,000 | -39,820,000 | -6,270,000 | ||
| 60-Month Beta | 0.39 | 0.58 | 1.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 11/12/24 | -0.20 on 03/25/25 | -0.18 on 03/25/25 | ||
| Latest Earnings Date | 05/13/25 | 05/01/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||